Michigan-based investment advisor Cedar Grove Capital Management recently released its third-quarter 2026 investor letter. The letter can be downloaded here.
Keep Reading →
October 7 - Hedge Fund Investor Letters, News
On August 13, Nektar Therapeutics (NASDAQ:NKTR) held its second-quarter earnings call and laid out where its lead drug candidate stands after years of development.
Keep Reading →
August 27 - Hedge Funds, News
In this article, we will take a look at some of the best mid-cap healthcare stocks that are being highly favored by hedge funds.
Keep Reading →
June 5 - Hedge Funds, News
Nektar Therapeutics (NASDAQ:NKTR) Q1 2026 Earnings Call Transcript May 8, 2026 Operator: Hello and thank you for standing by.
Keep Reading →
May 9 - News, Transcripts
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter can be downloaded here.
Keep Reading →
April 17 - Hedge Fund Investor Letters, News
Nektar Therapeutics (NASDAQ:NKTR) Q4 2025 Earnings Call Transcript March 12, 2026Nektar Therapeutics beats earnings expectations.
Keep Reading →
March 13 - News, Transcripts
We came across a bullish thesis on Nektar Therapeutics on Clinical Catalysts’s Substack. In this article, we will summarize the bulls’ thesis on NKTR.
Keep Reading →
February 2 - News, Stock Analysis
With strong 1-year returns and upside potential, Nektar Therapeutics (NASDAQ:NKTR) secures a spot on our list of the 12 best multibagger stocks to buy heading into 2026.
Keep Reading →
December 21 - News
In this article, we discuss the 12 Best Multibagger Stocks to Buy Heading into 2026.
Keep Reading →
December 19 - Hedge Funds, News
Nektar Therapeutics (NASDAQ:NKTR) is among the hottest SMID-cap stocks so far in 2025.
Keep Reading →
November 23 - News
Our list today highlights the 10 Hottest SMID-Cap Stocks So Far In 2025. SMID-caps, or Small- and mid-cap stocks, are often overlooked segments of the market.
Keep Reading →
November 22 - Hedge Funds, News
Nektar Therapeutics (NASDAQ:NKTR) Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Hello, and thank you for standing by.
Keep Reading →
November 8 - News, Transcripts
Nektar Therapeutics (NASDAQ:NKTR) is one of the hot stocks to buy with huge upside potential.
Keep Reading →
October 26 - News
On October 22, Vios Advisors’ Michael Bapis and BNY’s Alicia Levine joined CNBC's 'Closing Bell' to discuss the latest news affecting markets.
Keep Reading →
October 24 - Hedge Funds, News
Nektar Therapeutics (NASDAQ:NKTR) Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Welcome to the Nektar Therapeutics Second Quarter 2025 Financial Results Conference...
Keep Reading →
August 12 - News, Transcripts
Nektar Therapeutics (NASDAQ:NKTR) is one of the Stocks With Huge Catalysts on the Horizon.
Keep Reading →
July 29 - News
In this article, we will look at the 10 Stocks With Huge Catalysts on the Horizon.
Keep Reading →
July 28 - Hedge Funds, News
Nektar Therapeutics (NASDAQ:NKTR) is one of the best hot stocks to buy according to Wall Street analysts.
Keep Reading →
July 6 - News
On July 1, Ralph Schlosstein, Evercore's chairman emeritus and BlackRock's co-founder, joined 'Closing Bell Overtime' on CNBC to talk about his outlook for markets heading into...
Keep Reading →
July 5 - Hedge Funds, News
Nektar Therapeutics (NASDAQ:NKTR) Q1 2025 Earnings Call Transcript May 8, 2025Nektar Therapeutics misses on earnings expectations.
Keep Reading →
May 10 - News, Transcripts
The S&P 500 is down 8.6% in a month while the Nasdaq has lost nearly 13%.
Keep Reading →
March 19 - News, Stock Analysis
Nektar Therapeutics (NASDAQ:NKTR) Q4 2024 Earnings Call Transcript March 12, 2025Nektar Therapeutics misses on earnings expectations.
Keep Reading →
March 14 - News, Transcripts
In this article, we will look at the 12 Best Penny Stocks to Invest in According to the Media.
Keep Reading →
January 6 - Hedge Funds, News
Nektar Therapeutics (NASDAQ:NKTR) Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Good day and thank you for standing by.
Keep Reading →
November 9 - News, Transcripts
Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics isn't one of the 30 most popular stocks among hedge funds at the end of the ...
Keep Reading →
May 10 - News, Transcripts
Nektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcript March 4, 2024 Nektar Therapeutics misses on earnings expectations.
Keep Reading →
March 5 - News, Transcripts
Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript November 7, 2023 Nektar Therapeutics misses on earnings expectations.
Keep Reading →
November 9 - News, Transcripts
In this article, we will take a look at the 12 best penny stocks to buy under $1. To see more such companies, go directly to 5 Best Penny Stocks to Buy Under $1.
Keep Reading →
October 23 - Hedge Funds, News
Nektar Therapeutics (NASDAQ:NKTR) Q2 2023 Earnings Call Transcript August 8, 2023 Nektar Therapeutics misses on earnings expectations.
Keep Reading →
August 10 - News, Transcripts
Nektar Therapeutics (NASDAQ:NKTR) Q1 2023 Earnings Call Transcript May 9, 2023 Operator: Good day and thank you for standing by.
Keep Reading →
May 10 - News, Transcripts
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
Keep Reading →
April 20 - Hedge Funds, News
In this article, we look at why billionaire Stanley Druckenmiller just dumped 10 stocks from his portfolio. Meta Platforms, Inc. (NASDAQ:FB), Moderna, Inc.
Keep Reading →
March 1 - Hedge Funds, News
We can judge whether Nektar Therapeutics (NASDAQ:NKTR) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas...
Keep Reading →
December 10 - Hedge Funds, News
The biotech industry is regaining ground it lost in 2016 at full speed.
Keep Reading →
July 19 - Hedge Funds, News
Although the broader markets are relatively calm, five stocks, Nektar Therapeutics (NASDAQ:NKTR), Advanced Micro Devices, Inc.
Keep Reading →
March 20 - News
According to research firm TrimTabs, the dollar volume of insider buying from early-October through the end of last week stood at about $110 million, representing the lowest monthly...
Keep Reading →
October 26 - Insider Trading, News
Stocks indexes have jumped higher today amid better-than-expected earnings from Netflix, Inc. (NASDAQ:NFLX) and Goldman Sachs Group Inc (NYSE:GS), and a rally in oil prices.
Keep Reading →
October 18 - Market Movers, News
Cheyne Capital is one of the few non-U.S firms that we track in our database.
Keep Reading →
October 21 - Hedge Fund Analysis, Hedge Funds, News
Hedge Fund Resource Center 
